Sinphar Pharmaceutical Co., Ltd
Quick facts
Marketed products
- Orectalip · Other
Phase 2 pipeline
- Ergoloid Mesylates tablet
Acts as a mixed alpha-adrenergic antagonist and dopaminergic agonist to enhance cerebral metabolism and neurotransmitter function. - STA-1
- STA-2
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Sinphar Pharmaceutical Co., Ltd portfolio CI brief
- Sinphar Pharmaceutical Co., Ltd pipeline updates RSS
Frequently asked questions about Sinphar Pharmaceutical Co., Ltd
What are Sinphar Pharmaceutical Co., Ltd's marketed drugs?
Top marketed products include Orectalip.
Related
- Orectalip · Other
- Sector hub: All tracked pharma companies